Chronic migraine: Classification and comparisons

Katsarava, Zaza; Manack, Aubrey; Ms, Yoon; Obermann, Mark; Becker, Henri; Dommes, P; Turkel, Catherine C.; Lipton, RB; Hc, Diener

doi:10.1177/0333102410383590

Cited by 76 publications

(81 citation statements)

References 29 publications

(38 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The German Headache Consortium study is a longitudinal cohort study (9665 people) of the prevalence and incidence of headaches within the general population (age 18-65 years) [6]. Three definitions of CM were used: with the CM definition (equivalent to the ICHD-3 beta criteria) used in the PREEMPT trials (see Sect.…”

Section: …Still Interesting Results…mentioning

confidence: 99%

“…Using the S-L criteria, EM sufferers develop transformed migraine at a rate of 2.5 % per year [7]. [6] spontaneously remitted. Predictors of remission included lower baseline headache frequency (15-19 versus 25-31 headache days/month; odds ratio [OR] 0.29) and absence of allodynia (OR 0.45) [9,22].…”

Section: …Still Interesting Results…mentioning

confidence: 99%

“…It has also been suggested that posttraumatic stress disorder occurs at a significantly higher rate in persons with CM than in EM [13], which may be explained in a subgroup of patients by childhood maltreatment [14]. CM patients tend to have a higher Body Mass Index than EM patients, and around 25 % of CM patients are obese [6]. CM patients suffer more than twice as frequent (around 30 % of patients) from chronic non-headache pain disorders as compared to EM patients [10].…”

mentioning

confidence: 99%

“…The migraine attack is associated with sensitization of central nociceptive pathways (5), which can be detected by abnormalities of noxious evoked cortical and subcortical responses. The latter abnormalities amplify in CM, where the neurophysiological pattern is that of a « never-ending attack »; they spread in particular to thalamic and cortical levels (6). Because of the repeated pain attacks and possibly pre-existing comorbidities, connectivity of limbic areas with other cortical areas (7) and the descending pain control centres (8) is modified, which leads to abnormal central pain control and aggravates cortical abnormalities.…”

mentioning

confidence: 99%

See 3 more Smart Citations

Diagnosis, pathophysiology and management of chronic migraine: a proposal of the Belgian Headache Society

Paemeleire

Louis²,

Magis

et al. 2014

Acta Neurol Belg

View full text Add to dashboard Cite

Chronic migraine (CM) is a disabling neurological condition affecting 0.5-2 % of the population. In the current third edition of the International Classification of Headache Disorders, medication overuse is no longer an exclusion criterion and CM is diagnosed in patients suffering from at least 15 headache days per month of which at least eight are related to migraine. CM is difficult to treat, and preventive treatment options are limited. We provide a pathogenetic model for CM, integrating the latest findings from neurophysiological and neuroimaging studies. On behalf of the Belgian Headache Society, we present a management algorithm for CM based on the international literature and adapted to the Belgian situation. Pharmacological treatment options are discussed, and recent data on transcranial and invasive neuromodulation studies in CM are reviewed. An integrated multimodal treatment programme may be beneficial to refractory patients, but at present, this approach is only supported by a limited number of observational studies and quite variable between centres

show abstract

Section: …Still Interesting Results…mentioning

confidence: 99%

Section: …Still Interesting Results…mentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 2 more Smart Citations

Diagnosis, pathophysiology and management of chronic migraine: a proposal of the Belgian Headache Society

Paemeleire

Louis²,

Magis

et al. 2014

Acta Neurol Belg

View full text Add to dashboard Cite

show abstract

“…4 In Latin America, a multicenter study conducted in Argentina, Brazil, Colombia, Mexico and Venezuela found that 62% of the participants suffered from headaches, and that the prevalence of migraine among women was 6.1% to 17.4%, while that among men was 2.9% to 7.8%. 5 Furthermore, several studies have identified a subgroup of patients who experience chronic migraine, 6,7 in which headache occurs on at least 15 days per month for more than 3 months, 2,8 with features of migraine headache on at least 8 days per month.…”

Section: Introductionmentioning

confidence: 99%

The effectiveness of aspirin for migraine prophylaxis: a systematic review

et al. 2017

View full text Add to dashboard Cite

CONTEXT AND OBJECTIVE: Many researchers have suggested that aspirin prevents migraines. However, the evidence is unclear. The aim of this study was to analyze the available evidence on the effect of aspirin as a migraine prophylactic. DESIGN AND SETTING: Systematic review, conducted at the Pontifícia Universidade Católica do Paraná, Brazil, and at the University of São Paulo, Brazil. METHODS:We performed electronic searches in the databases of MEDLINE/PubMed, Embase, WEB OF SCIENCE, the World Health Organization, CENTRAL and OpenGrey, and we also searched manually for interventional studies published before April 2016 that compared the effects of aspirin with a control, in adults. Two authors independently extracted data on the publication, population recruited, intervention (aspirin dosage, follow-up and combined treatment) and main outcomes (frequency, severity and duration of migraine). We evaluated the quality of the studies using the Cochrane risk-of-bias tool. RESULTS: Our search retrieved 1,098 references, of which 8 met the selection criteria for this systematic review. The total population was 28,326 participants (18-64 years old); most (96%) were men. The dosage varied from 50 to 650 mg/day across the studies. The risk of bias was generally low or unclear. The only outcome for which most of the studies included (6/8) reported a significant reduction was frequency of migraine, which was reduced at an aspirin dosage of at least 325 mg/day. CONCLUSION: Aspirin can reduce the frequency of migraines. However, the optimal dosage is unclear. RESUMO

show abstract

Spinal rehabilitative exercise and manual treatment for the prevention of migraine attacks in adults

Brønfort¹,

Evans²,

Goldsmith³

et al. 2015

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Chronic migraine: Classification and comparisons

Abstract: CM prevalence varies by case definition. The epidemiological profiles of the three CM groups are similar but differ significantly from those of HFEM and LFEM. Optimal definitions for clinical practice and epidemiological research require additional field testing.

Cited by 76 publications

References 29 publications

Diagnosis, pathophysiology and management of chronic migraine: a proposal of the Belgian Headache Society

Diagnosis, pathophysiology and management of chronic migraine: a proposal of the Belgian Headache Society

The effectiveness of aspirin for migraine prophylaxis: a systematic review

Spinal rehabilitative exercise and manual treatment for the prevention of migraine attacks in adults

Contact Info

Product

Resources

About